Prostate Cancer Therapeutics Market: Global Market Size, Industry Growth, Future Prospects, Opportunities and Forecast 2019-2025

Advances in prostate cancer have been witnessed across the countries, such as the US, Canada, China, and Germany. In the US, National Cancer Institute (NCI) offers funding to the researchers to advance the understanding regarding prevention, detection, and treatment of prostate cancer. Most men diagnosed with prostate cancer can live a long time; however, challenges remain while opting for the best treatments for individuals at all disease stages. Therefore, scientists at NCI are working for the development of advanced alternatives for prostate cancer for more accurate treatment of the patients, which in turn, will drive the global prostate cancer therapeutics market. 

A full report description of "Prostate Cancer Therapeutics Market Size, Share & Trends Analysis Report and Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/prostate-cancer-therapeutics-market 

NCI scientists have developed a procedure that integrates magnetic resonance imaging (MRI) with transrectal ultrasound (TRUS) for highly accurate prostate biopsies. MRI can identify potential areas of cancer within the gland, however, is not practical for real-time imaging for guidance in prostate biopsy. Fusion biopsy is a new procedure that uses a computer to fuse an MRI image with an ultrasound image. This allows doctors to use guided ultrasound to biopsy areas of possible cancer seen on MRI. In a clinical trial, referred to as the Prostate Evaluation for Clinically Important Disease (PRECISION) trial, an MRI targeted biopsy approach was highly successful for identifying higher-grade cancers that were possible needs treatment as compared to biopsies performed with only ultrasound guidance.

 To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/prostate-cancer-therapeutics-market 

Fusion biopsy was also better in terms of detecting low-grade cancers that were not likely to require treatment. The scientists are also testing the utilization of machine learning, also known as artificial intelligence (AI) technology that can support to effectively recognize suspicious areas in a prostate MRI. The technology is also being tested to improve the evaluation of biopsy samples for more accurate identification of which cancer need to be treated and which could be managed applying active surveillance. The advent of AI in medical diagnosis could lead to a more efficient and reliable diagnosis, which in turn, will propel the growth of the global prostate cancer diagnostics and therapeutics market.

NCI-led researchers are working to develop new imaging methods to improve the diagnosis of recurrent prostate cancer. A protein known as prostate-specific membrane antigen (PSMA) is found in large quantities and nearly exclusively on prostate cells. By fusing a molecule that attaches to PSMA to a compound utilized in positron emission tomography (PET) scan imaging, the scientists can see tiny deposits of prostate cancer that are very small to be detected using regular imaging. This could support doctors and patients to make better-informed treatment decisions for metastatic prostate cancer. For instance, when a man is first diagnosed and small amounts metastatic cancer is found, hormone therapy may be chosen rather than surgery. 

Additionally, this may allow doctors for treatment of cancer recurrence, either in the prostate or metastatic disease earlier, which may lead to better survival. Early detection can help in prevention and even curing the disease at its early stages which prove to be better than when treated at a later stage. These initiatives for accurate diagnosis of the condition can support doctors to recommend effective treatment to the patient, which leads to an increase in the patients’ chances of survival. As a result, such advances in prostate cancer tend to promote the adoption of advanced prostate cancer diagnostic instruments and thereby promoting the growth of the global prostate cancer therapeutics market. 

Visit here to know more about Global Prostate Cancer Therapeutics Market 

Global Prostate Cancer Therapeutics Market- Segmentation 
By Treatment 
  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Targeted Therapy
Global Prostate Cancer Therapeutics Market– Segment by Region  

North America          
  • US
  • Canada 
Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe 
Asia-Pacific   
  • China
  • Japan
  • India
  • Rest of Asia-Pacific 
Rest of the World 
  • Middle East & Africa 
  • Latin America 
About Orion Market Research

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Contact no: +1 646-755-7667, +91 780-304-0404

Comments

Post a Comment

Popular posts from this blog

Information System Audit Services Market to Witness Robust Expansion by 2028

Information System Audit Services Market research report greatly helps to understand comprehensive profile of ideal customers. It also ascertains the market size for your business. Understanding of customers has great significance in the business expansion as it allows making right investment in the product development and launch. Making more informed decision is easy with this market research report. Identifying right business opportunities and maintaining customer-centric approach is easy with this market research report. It also enables to stay on the top of market trends and helps to reduce business risks. Information System Audit Services Market study report provides best solutions to deal with upcoming challenges. Market research serves as a valuable tool to stay up on current trends and know forthcoming competitive scenario for the estimation period 2022-2028. Get Sample Copy of this Report at   https://orionmarketreports.com/request-sample/?id=217315 Information System Audit Se
Read more

Impact of COVID-19 on Italy Ventilator Industry Share, Trends and Forecast to 2025

As the whole world is fighting against COVID-19, the demand for ventilators has emerged significantly in healthcare facilities. Ventilators are mechanical breathing devices that are used to blow oxygen and air into the lungs. These devices are important for delivering care to people suffering from lung failure, which is one of the complications among patients with severe COVID-19. Italy is among one of the nation’s requiring a significant number of ventilators amid COVID-19 to help patients breathe easier.  A full report description of  Impact of COVID-19 on Italy Ventilator Industry  https://www.omrglobal.com/industry-reports/impact-of-covid-19-on-italy-ventilator-industry   The global spread of coronavirus has put ventilator manufacturers under pressure to ramp up production. Due to the epidemic, the supply of essential components has disrupted, which include valves, hoses, and motors. In addition, most of the electronic products come from China which is further disrupting
Read more

North American Electric Vehicle Charger Market Growth, Size, Share, Industry Report and Forecast to 2019-2025

North American electric vehicle charger market is forecast to grow at a considerable growth rate over the forecast period, 2019-2025. Some of the major factors for the growth of the market include rising electric vehicle market, cohesive government regulations for electric vehicles & its charging infrastructure and significant investment from the government and private companies in developing charging infrastructure in the region. High average cost of the IC engine-based automobile is another major factor for the growth of the market. Some of the major electric vehicle companies working in the region include BMW AG, Audi AG, Ford Motors Co., Jaguar Land Rover, Tesla, Inc., Volkswagen AG and so on. The companies are expected to invest a considerable amount in developing charging infrastructure in the region. For instance, in May 2019 Volkswagen AG aims to develop 2,000 charging stations under its Electrify America program.   A full Report of North American Electric Vehicle Cha
Read more